Lisa A. Marsch, PhD
Dartmouth College Director
Center for Technology and Behavioral Health Director
Northeast Node National Drug Abuse Treatment Clinical Trials Network Andrew G. Wallace Professor Geisel School of Medicine at Dartmouth
Lisa A. Marsch, PhD is the Director of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network (CTN), the Director of the NIDA-funded P30 Center for Technology and Behavioral Health (CTBH; a P30 “Center of Excellence”), and the Andrew G. Wallace Professor of Psychiatry within the Geisel School of Medicine at Dartmouth College.
As Director of the Northeast Node of the NIDA CTN, Dr. Marsch leads a broad partnership of stakeholders focused on research and dissemination activities addressing the most timely and significant issues related to substance use disorder care.
As a national interdisciplinary Center, CTBH uses science to inform the development, evaluation, and strategic implementation of technology (web, mobile, sensing)-based tools for behavior change targeting substance use disorders and related behavioral health issues. These tools are designed to deliver engaging and effective self-monitoring and digital therapeutic interventions to promote health behavior and are designed to collectively lead to transformations in the delivery of science-based health care.
Dr. Marsch has led numerous research projects supported by the National Institute on Drug Abuse. She publishes extensively and averages 2-3 invited presentations per month (and over 400 presentations in total) at both national and international scientific meetings (including invited presentations at the White House, Congressional briefings, and for the US Surgeon General, as well as an array of national meetings for NIH, SAMHSA and many other organizations). She regularly participates in media and advisory activities in the U.S. and internationally (e.g., Fox News, Associated Press, ABC, NIDA TV, SAMHSA TV, NPR, US News and World Reports, BBC), and has served on over 60 scientific peer review committees for NIH and on the Editorial Board of several scientific journals. She serves on the National Advisory Council to the National Institute on Drug Abuse. And she has served as a consultant to the Department of Mental Health and Substance Abuse at the World Health Organization.